Guidance for market authorization requirements for COVID-19 drugs: Quality and manufacturing requirements

Name: Guidance for market authorization requirements for COVID-19 drugs: Quality and manufacturing requirements
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

COVID-19 drugs must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with the international requirements outlined in the International Council for Harmonization Q7A guideline and with applicable Health Canada's guidance.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2022-07-28

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Guidance for market authorization requirements for COVID-19 drugs: Quality and manufacturing requirements (English, HTML) HTML
Guidance for market authorization requirements for COVID-19 drugs: Quality and manufacturing requirements (French, HTML) HTML

Related open data

Health Canada